InsidersTradesSigma
Total declarations
Company
▲ Purchases (18 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
18
Disclosed sells
0
T+90 hit rate
10%
T+90 mean return
-23.6%
Across 20 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by DEPASQUALE MICHAEL W, Chief Executive Officer. Insider active across 1 company, notably BIO KEY International INC. Aggregated, 31 filings have been recorded. Breakdown: 18 buys · 0 sell. Total volume traded: €105k. History available since 20 May 2021. The latest transaction was filed on 15 September 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations31 total
250 sharesCommon StockSEC:0001437749-26-022517:0
2,500 shares@ US$0.752.1% of flowCommon StockSEC:0001437749-25-029320
Ideal exit: 12 Jun 2026 (T+270)
2,500 shares@ US$0.750.035% mcap2.1% of flowCommon StockSEC:0001437749-25-029320:0
Ideal exit: 12 Jun 2026 (T+270)
139 shares@ US$1.400.2% of flowCommon StockSEC:0001437749-25-000213:0
24,000 shares0Common StockSEC:0001437749-24-024503:0
24,000 shares0Common StockSEC:0001437749-24-024515:0
139 shares@ US$1.3940.2% of flowCommon StockSEC:0001437749-24-022004:0
139 shares@ US$2.550.3% of flowCommon StockSEC:0001437749-24-000439:0
20,000 shares@ US$0.182.8% of flowCommon StockSEC:0001437749-23-033457:0
Ideal exit: 27 Aug 2024 (T+270)
165,000 shares@ US$0.17522.9% of flowCommon StockSEC:0001437749-23-029784:0
Ideal exit: 26 Jul 2024 (T+270)
100 shares@ US$0.510.0% of flowCommon StockSEC:0001437749-23-025845:0
Ideal exit: 8 Jun 2024 (T+270)
35,000 shares0Common StockSEC:0001437749-23-024950:0
2,500 shares@ US$0.49731.0% of flowCommon StockSEC:0001437749-23-019324:0
5,000 shares@ US$0.7152.7% of flowCommon StockSEC:0001437749-23-017774:0
Ideal exit: 12 Mar 2024 (T+270)
2,500 shares@ US$0.49731.0% of flowCommon StockSEC:0001437749-23-000716:0
1,000 shares@ US$1.68761.4% of flowCommon StockSEC:0001437749-22-022571:0
Ideal exit: 12 Jun 2023 (T+270)
1,265 shares@ US$1.601.7% of flowCommon StockSEC:0001437749-22-022488:0
Ideal exit: 11 Jun 2023 (T+270)
2,500 shares@ US$1.50453.0% of flowCommon StockSEC:0001437749-22-016562:0
2,000 shares@ US$1.660.071% mcap4.2% of flowCommon StockSEC:0001437749-22-015017:0
Ideal exit: 11 Mar 2023 (T+270)
2,500 shares@ US$1.800.093% mcap5.6% of flowCommon StockSEC:0001437749-22-013599:0
Ideal exit: 20 Feb 2023 (T+270)
35,000 shares0Common StockSEC:0001437749-22-006309:0
2,500 shares@ US$1.883.5% of flowCommon StockSEC:0001437749-22-000295
2,500 shares@ US$1.880.092% mcap5.5% of flowCommon StockSEC:0001437749-22-000295:0
2,500 shares@ US$2.550.13% mcap7.5% of flowCommon StockSEC:0001437749-21-027506:0
Ideal exit: 26 Aug 2022 (T+270)
2,500 shares@ US$2.554.7% of flowCommon StockSEC:0001437749-21-027506
Ideal exit: 26 Aug 2022 (T+270)
25 of 31 declarations
About DEPASQUALE MICHAEL W
Michael W. DePasquale is the Chief Executive Officer of BIO KEY INTERNATIONAL INC.
